NO20031071L - Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien - Google Patents
Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveienInfo
- Publication number
- NO20031071L NO20031071L NO20031071A NO20031071A NO20031071L NO 20031071 L NO20031071 L NO 20031071L NO 20031071 A NO20031071 A NO 20031071A NO 20031071 A NO20031071 A NO 20031071A NO 20031071 L NO20031071 L NO 20031071L
- Authority
- NO
- Norway
- Prior art keywords
- agent
- inhibiting
- inhibition
- closing
- decrease
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Surgical Instruments (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
Oppfinnelsen angår en fremgangsmåte for å inhibere nedgang i den transdermale gjennomstrømning av et middel som transdermalt avleveres eller det tas prøver av over en lengre tidsperiode, der avleveringen eller innsamlingen involverer ødeleggelse av minst stratum corneumlaget av huden for å danne overføringsveier gjennom hvilket middelet kan passere. Det ønskete resultat oppnås ved samtidig tilførsel eller samtidig innsamling av middelet med en mengde av minst ett ikke-sårhelende middel der mengden av det ikke-sårhelende middel er effektivt til å inhibere nedgangen i middelets transdermale gjennomstrømning, sammenliknet med når avleveringen eller prøvetakingen av middelet utføres under hovedsakelig identiske betingelser med unntak av fravær av det ikke-sårhelende middel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23116000P | 2000-09-08 | 2000-09-08 | |
PCT/US2001/027551 WO2002019985A2 (en) | 2000-09-08 | 2001-09-06 | Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20031071D0 NO20031071D0 (no) | 2003-03-07 |
NO20031071L true NO20031071L (no) | 2003-05-06 |
Family
ID=22867983
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20031071A NO20031071L (no) | 2000-09-08 | 2003-03-07 | Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien |
Country Status (24)
Country | Link |
---|---|
US (1) | US7438926B2 (no) |
EP (1) | EP1335711B1 (no) |
JP (2) | JP5507030B2 (no) |
KR (1) | KR100764699B1 (no) |
CN (1) | CN100421653C (no) |
AT (1) | ATE367805T1 (no) |
AU (2) | AU2001288774B2 (no) |
BR (1) | BR0113749A (no) |
CA (1) | CA2422200A1 (no) |
CZ (1) | CZ2003687A3 (no) |
DE (1) | DE60129585T2 (no) |
DK (1) | DK1335711T3 (no) |
EE (1) | EE200300095A (no) |
ES (1) | ES2290166T3 (no) |
IL (1) | IL154811A0 (no) |
MA (1) | MA25958A1 (no) |
MX (1) | MXPA03002122A (no) |
NO (1) | NO20031071L (no) |
NZ (1) | NZ524646A (no) |
PL (1) | PL365603A1 (no) |
PT (1) | PT1335711E (no) |
RU (1) | RU2272618C2 (no) |
WO (1) | WO2002019985A2 (no) |
ZA (1) | ZA200302700B (no) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0113749A (pt) * | 2000-09-08 | 2004-06-22 | Alza Corp | Métodos para inibir a diminuição no fluxo de droga transdérmica por inibição do fechamento das vias |
EP2085109A3 (en) * | 2000-10-26 | 2009-09-02 | Alza Corporation | Transdermal drug delivery devices having coated microprotrusions |
US6908453B2 (en) * | 2002-01-15 | 2005-06-21 | 3M Innovative Properties Company | Microneedle devices and methods of manufacture |
EP1638523B8 (en) * | 2003-06-30 | 2013-12-25 | ALZA Corporation | Formulations for coated microprojections containing non-volatile counterions |
PE20050288A1 (es) * | 2003-07-02 | 2005-04-29 | Alza Corp | Metodo y parche de inmunizacion por disposicion de microproyeccion |
WO2005020912A2 (en) | 2003-08-25 | 2005-03-10 | 3M Innovative Properties Company | Delivery of immune response modifier compounds |
JP2007519613A (ja) * | 2003-10-23 | 2007-07-19 | アルザ・コーポレーシヨン | 微小突出部をコーティングするための安定化されたdnaの組成物 |
KR20060108682A (ko) | 2003-10-24 | 2006-10-18 | 알자 코포레이션 | 경피 약물 전달을 증대시키기 위한 전처리 방법 및 장치 |
AU2004292954A1 (en) * | 2003-11-13 | 2005-06-09 | Alza Corporation | Composition and apparatus for transdermal delivery |
WO2005099751A2 (en) | 2004-04-01 | 2005-10-27 | Alza Corporation | Apparatus and method for transdermal delivery of influenza vaccine |
JP2007532645A (ja) * | 2004-04-13 | 2007-11-15 | アルザ コーポレイション | フェンタニルに基づく薬剤の経皮送達システム用の器具および方法 |
KR20070011481A (ko) * | 2004-04-13 | 2007-01-24 | 알자 코포레이션 | 다중 백신의 경피 전달용 기구 및 방법 |
US20060034903A1 (en) * | 2004-08-11 | 2006-02-16 | Yuh-Fun Maa | Apparatus and method for transdermal delivery of natriuretic peptides |
CA2588080C (en) * | 2004-11-18 | 2013-01-08 | 3M Innovative Properties Company | Masking method for coating a microneedle array |
KR101246015B1 (ko) | 2004-11-18 | 2013-03-20 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 마이크로니들 어레이를 접촉 코팅하는 방법 |
US8057842B2 (en) | 2004-11-18 | 2011-11-15 | 3M Innovative Properties Company | Method of contact coating a microneedle array |
EP1853231A2 (en) * | 2005-02-16 | 2007-11-14 | Alza Corporation | Apparatus and method for transdermal delivery of erythropoetin-based agents |
US20070270738A1 (en) * | 2005-04-25 | 2007-11-22 | Wu Jeffrey M | Method of treating ACNE with stratum corneum piercing patch |
US20060253079A1 (en) * | 2005-04-25 | 2006-11-09 | Mcdonough Justin | Stratum corneum piercing device |
US20080195035A1 (en) * | 2005-06-24 | 2008-08-14 | Frederickson Franklyn L | Collapsible Patch and Method of Application |
US20070078414A1 (en) * | 2005-08-05 | 2007-04-05 | Mcallister Devin V | Methods and devices for delivering agents across biological barriers |
EP1948139A4 (en) * | 2005-11-18 | 2012-04-04 | 3M Innovative Properties Co | COATING COMPOSITIONS, COATINGS DERIVED THEREFROM, AND MICRO-NETWORKS COMPRISING SUCH COATINGS |
EP2018835B1 (de) * | 2007-07-09 | 2014-03-05 | Augustinus Bader | Wirkstoff abgebendes Pflaster |
US8617487B2 (en) | 2009-03-25 | 2013-12-31 | Venture Lending & Leasing Vi, Inc. | Saliva sample collection systems |
JPWO2011010456A1 (ja) * | 2009-07-24 | 2012-12-27 | 株式会社ネクスト21 | NSAIDs含有外用剤及び当該外用剤の製造方法 |
EP2818159A1 (de) * | 2013-06-25 | 2014-12-31 | LTS LOHMANN Therapie-Systeme AG | Vorrichtung mit transdermalem therapeutischem System, Positionier- und Penetrationshilfe |
US9987361B1 (en) * | 2014-12-29 | 2018-06-05 | Noven Pharmaceuticals, Inc. | Compositions and method for sustained drug delivery by active transdermal technology |
DE102017126501A1 (de) | 2017-11-10 | 2019-05-16 | Lts Lohmann Therapie-Systeme Ag | Mikronadelsystem zur Applikation eines Hepatitis-Impfstoffes |
US20190231925A1 (en) * | 2018-01-31 | 2019-08-01 | Changchun Ja Biotech. Co., Ltd. | Heparin sodium supported hydrogel sustained-release paster |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE25637E (en) | 1964-09-08 | Means for vaccinating | ||
US3964482A (en) | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
BE795384A (fr) | 1972-02-14 | 1973-08-13 | Ici Ltd | Pansements |
EP0429842B1 (en) | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
US5279544A (en) | 1990-12-13 | 1994-01-18 | Sil Medics Ltd. | Transdermal or interdermal drug delivery devices |
IL109037A (en) * | 1993-03-19 | 1999-01-26 | Cellegy Pharma Inc | Preparations for causing phase separation of lipid layers and preparation of the above preparations |
US5885211A (en) | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
US5458140A (en) | 1993-11-15 | 1995-10-17 | Non-Invasive Monitoring Company (Nimco) | Enhancement of transdermal monitoring applications with ultrasound and chemical enhancers |
CA2205444A1 (en) * | 1994-12-09 | 1996-06-13 | Novartis Ag | Transdermal system |
WO1996037256A1 (en) | 1995-05-22 | 1996-11-28 | Silicon Microdevices, Inc. | Micromechanical patch for enhancing the delivery of compounds through the skin |
AU5740496A (en) | 1995-05-22 | 1996-12-11 | General Hospital Corporation, The | Micromechanical device and method for enhancing delivery of compounds through the skin |
DE19525607A1 (de) | 1995-07-14 | 1997-01-16 | Boehringer Ingelheim Kg | Transcorneales Arzneimittelfreigabesystem |
US5902603A (en) * | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
DE19541260A1 (de) * | 1995-11-06 | 1997-05-07 | Lohmann Therapie Syst Lts | Therapeutische Zubereitung zur transdermalen Applikation von Wirkstoffen durch die Haut |
AR008242A1 (es) | 1996-06-18 | 1999-12-29 | Alza Corp | Dispositivo para atravesar el estrato corneo de una superficie corporal |
US6183434B1 (en) | 1996-07-03 | 2001-02-06 | Spectrx, Inc. | Multiple mechanical microporation of skin or mucosa |
DE69718495T2 (de) | 1996-09-17 | 2003-11-20 | Deka Products Lp | System zur medikamentenabgabe durch transport |
AU722574B2 (en) | 1996-12-20 | 2000-08-10 | Alza Corporation | Device and method for enhancing transdermal agent flux |
DE19654391A1 (de) | 1996-12-27 | 1998-07-02 | Basf Ag | Katalysator zur selektiven Herstellung von Propylen aus Propan |
WO1998029134A2 (en) * | 1996-12-31 | 1998-07-09 | Altea Technologies, Inc. | Microporation of tissue for delivery of bioactive agents |
US6918901B1 (en) * | 1997-12-10 | 2005-07-19 | Felix Theeuwes | Device and method for enhancing transdermal agent flux |
CN1206004C (zh) * | 1997-12-11 | 2005-06-15 | 阿尔扎有限公司 | 增强透皮物剂流量的装置 |
CN1170603C (zh) * | 1997-12-11 | 2004-10-13 | 阿尔扎有限公司 | 增强透皮物剂流量的装置 |
KR100572539B1 (ko) * | 1997-12-11 | 2006-04-24 | 알자 코포레이션 | 경피성 작용제 유동률을 증진시키기 위한 장치 |
US6022316A (en) | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
JP2002517300A (ja) | 1998-06-10 | 2002-06-18 | ジョージア テック リサーチ コーポレイション | 微小針デバイスおよび製造方法ならびにそれらの使用 |
WO2000069515A1 (en) * | 1999-05-17 | 2000-11-23 | Marchitto Kevin S | Remote and local controlled delivery of pharmaceutical compounds using electromagnetic energy |
EP1187653B1 (en) * | 1999-06-04 | 2010-03-31 | Georgia Tech Research Corporation | Devices for enhanced microneedle penetration of biological barriers |
AU782610B2 (en) * | 1999-12-10 | 2005-08-11 | Alza Corporation | Skin treatment apparatus for sustained transdermal drug delivery |
DK1239916T3 (da) * | 1999-12-10 | 2006-04-03 | Alza Corp | Indretning og fremgangsmåde til at forbedre perforering af hud med mikrofremspring |
BR0113749A (pt) * | 2000-09-08 | 2004-06-22 | Alza Corp | Métodos para inibir a diminuição no fluxo de droga transdérmica por inibição do fechamento das vias |
EP2085109A3 (en) * | 2000-10-26 | 2009-09-02 | Alza Corporation | Transdermal drug delivery devices having coated microprotrusions |
WO2004030743A2 (en) * | 2002-09-30 | 2004-04-15 | Alza Corporation | Drug delivery device having coated microprojections incorporating vasoconstrictors |
-
2001
- 2001-09-06 BR BR0113749-2A patent/BR0113749A/pt not_active IP Right Cessation
- 2001-09-06 AU AU2001288774A patent/AU2001288774B2/en not_active Ceased
- 2001-09-06 PL PL01365603A patent/PL365603A1/xx not_active Application Discontinuation
- 2001-09-06 AT AT01968531T patent/ATE367805T1/de not_active IP Right Cessation
- 2001-09-06 NZ NZ524646A patent/NZ524646A/en unknown
- 2001-09-06 IL IL15481101A patent/IL154811A0/xx unknown
- 2001-09-06 MX MXPA03002122A patent/MXPA03002122A/es active IP Right Grant
- 2001-09-06 CN CNB018185835A patent/CN100421653C/zh not_active Expired - Fee Related
- 2001-09-06 DE DE60129585T patent/DE60129585T2/de not_active Expired - Lifetime
- 2001-09-06 EE EEP200300095A patent/EE200300095A/xx unknown
- 2001-09-06 CZ CZ2003687A patent/CZ2003687A3/cs unknown
- 2001-09-06 EP EP01968531A patent/EP1335711B1/en not_active Expired - Lifetime
- 2001-09-06 KR KR1020037003472A patent/KR100764699B1/ko not_active IP Right Cessation
- 2001-09-06 AU AU8877401A patent/AU8877401A/xx active Pending
- 2001-09-06 CA CA002422200A patent/CA2422200A1/en not_active Abandoned
- 2001-09-06 RU RU2003109743/15A patent/RU2272618C2/ru not_active IP Right Cessation
- 2001-09-06 WO PCT/US2001/027551 patent/WO2002019985A2/en active IP Right Grant
- 2001-09-06 JP JP2002524470A patent/JP5507030B2/ja not_active Expired - Fee Related
- 2001-09-06 DK DK01968531T patent/DK1335711T3/da active
- 2001-09-06 ES ES01968531T patent/ES2290166T3/es not_active Expired - Lifetime
- 2001-09-06 PT PT01968531T patent/PT1335711E/pt unknown
- 2001-09-08 US US09/950,436 patent/US7438926B2/en not_active Expired - Fee Related
-
2003
- 2003-03-07 NO NO20031071A patent/NO20031071L/no not_active Application Discontinuation
- 2003-04-07 ZA ZA200302700A patent/ZA200302700B/en unknown
- 2003-04-07 MA MA27093A patent/MA25958A1/fr unknown
-
2013
- 2013-07-09 JP JP2013143738A patent/JP2013256500A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ATE367805T1 (de) | 2007-08-15 |
JP2013256500A (ja) | 2013-12-26 |
DK1335711T3 (da) | 2007-11-26 |
ES2290166T3 (es) | 2008-02-16 |
AU8877401A (en) | 2002-03-22 |
CA2422200A1 (en) | 2002-03-14 |
IL154811A0 (en) | 2003-10-31 |
EP1335711A2 (en) | 2003-08-20 |
US7438926B2 (en) | 2008-10-21 |
ZA200302700B (en) | 2004-08-13 |
DE60129585T2 (de) | 2008-04-17 |
PT1335711E (pt) | 2007-09-05 |
RU2272618C2 (ru) | 2006-03-27 |
MA25958A1 (fr) | 2003-12-31 |
US20020102292A1 (en) | 2002-08-01 |
EP1335711B1 (en) | 2007-07-25 |
JP2004508319A (ja) | 2004-03-18 |
DE60129585D1 (de) | 2007-09-06 |
NO20031071D0 (no) | 2003-03-07 |
KR20030074595A (ko) | 2003-09-19 |
MXPA03002122A (es) | 2004-09-10 |
BR0113749A (pt) | 2004-06-22 |
AU2001288774B2 (en) | 2006-06-29 |
JP5507030B2 (ja) | 2014-05-28 |
EE200300095A (et) | 2005-02-15 |
WO2002019985A2 (en) | 2002-03-14 |
WO2002019985A3 (en) | 2002-09-06 |
PL365603A1 (en) | 2005-01-10 |
CN1473037A (zh) | 2004-02-04 |
NZ524646A (en) | 2004-10-29 |
CZ2003687A3 (cs) | 2004-01-14 |
KR100764699B1 (ko) | 2007-10-08 |
CN100421653C (zh) | 2008-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20031071L (no) | Fremgangsmåte for å inhibere nedgang i transdermal medikamentgjennomströmming ved inhibisjon ved lukking av reaksjonsveien | |
WO2003032914A3 (en) | Methods for treating substance abuse with cholinesterase inhibitors | |
WO2005018677A3 (en) | Use of combination of an epidermal growth factor receptor kinase inhibitor and cytotoxic agents for treatment and inhibition of cancer | |
EP1418976A4 (en) | DEVICES AND METHODS FOR THE TITRATION OF MEDICINAL RELEASE | |
WO2004006906A3 (en) | Methods for the treatment of neoplasms | |
WO2009129509A3 (en) | Methods and compositions for treating post-operative pain comprising a local anesthetic | |
MX2009005201A (es) | Derivados de estratrieno sustituidos como inhibidores de 17beta hsd. | |
SI1624878T1 (sl) | Uporaba sestavkov, ki obsegajo estrogensko komponento, za zdravljenje in preprecevanje muskuloskeletne bolecine | |
WO2006047392A3 (en) | Nicotinic-opioid synergy for analgesia | |
WO2006068796A3 (en) | Inhibitors of akt activity | |
WO2007149782A3 (en) | Selective inhibitors for transferases | |
WO2002049630A3 (en) | Method for preventing or treating pain by administering an endothelin antagonist | |
WO2005044194A3 (en) | TREATMENT OR PREVENTION OF NEOPLASIA BY USE OF AN Hsp90 INHIBITOR | |
WO2007123511A3 (en) | Dosing regimens for the treatment of cancer | |
WO2005077082A3 (en) | INHIBITING CAV3 ISOFORMS AND THE δ25B SPLICE VARIENTS FOR THE DIAGNOSIS AND TREATMENT OF CANCER | |
WO2003092606A3 (en) | Cholinesterase inhibitors to prevent injuries caused by chemicals | |
WO2001087343A3 (en) | Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor | |
WO2007143185A3 (en) | Transdermal treatment of tendinopathy using glyceryl trinitrite | |
WO2002096351A3 (en) | Ultrashort-acting opioids for transdermal application | |
WO2005037347A3 (en) | Treatment of overuse tendinopathy using transdermal nitric oxide-generating agents | |
HUP9801022A2 (hu) | Eljárás aldóz reduktáz inhibítor alkalmazása diabetikus szívizom-betegség megelőzésére vagy megfordítására | |
WO2004007676A3 (en) | Combination therapy for the treatment of neoplasms | |
WO2007103190A3 (en) | Transdermal treatment of tendinop athy using no donor | |
HK1122504A1 (en) | Use of preparation of drugs for treatment and prevention of benign pigmented moles(naevi) using artemisinine and the derivatives thereof | |
GEP201606538B (en) | Preoperative treatment of post operative pain |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |